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Fate specification of multipotent cells is a highly regulated process during development of 
an organism to ensure that the right cell types are forming in the right locations. Many Polycomb-
group genes are known to function in chromatin regulation and regulation of gene expression 
during early development. The Additional Sex Combs - Like 3 (ASXL3) gene is a putative 
Polycomb-group gene thought to function in a complex called polycomb-repressive 
deubiqitination complex (PR-DUB), which removes a ubiquitin mark on histone H2A. The PR-
DUB complex works antagonistically to polycomb repressive complex 1 (PRC1), which adds a 
repressive ubiquitin mark to histone H2A. These two complexes dynamically regulate the 
ubiquitination of H2A, and are thus termed the H2A monoubiquitination regulatory axis. 
Pathogenic variants in ASXL3 have previously been identified as the genetic basis of Bainbridge 
Ropers Syndrome (BRS), a developmental disorder with syndromic features of autism spectrum 
disorder. Early work in my lab demonstrated that changes in H2A ubiquitination levels were the 
key molecular pathology leading to the symptoms in BRS patients. This thesis aims to further 
characterize the role of ASXL3 in early development, specifically on the development of the brain 
and the heart. Our work with an Asxl3 knockout mouse model has shown that ASXL3 plays an 
important role in differentiation of neural progenitor cells into layer 5 upper motor neurons and in 
controlling proliferation and differentiation dynamics during the process of cardiogenesis. 
Together, our data suggests an important role for ASXL3-dependent H2AUb1 regulation during 
fate specification events of several organ systems.  
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During early development, cells are pluripotent, meaning that they have the ability to 
become a variety of different specialized cell types. Over time, as the organism develops, it 
requires certain cell types at specific times and locations. Even within organs, there is a particular 
structure and organization that must be achieved. In order to meet this need, pluripotent cells 
throughout the organism commit to particular fates via a highly orchestrated process. This process 
of commitment is permanent; once a cell takes on a particular fate, it cannot go back and regain its 
pluripotency. The irreversible nature of this differentiation process means that it is critical that 
cells differentiate properly and accurately. If a cell takes on the wrong fate or differentiates at the 
wrong time, it could have immense downstream effects on the overall development of the 
organism. Cell plasticity is thus very important for early development because it allows for 
multiple different cell types to grow from a common pool of pluripotent cells (Yadav et al. 2018). 
Tight regulation of the fate specification and differentiation processes is necessary to ensure that 
highly specialized cells are born in the right locations and at the right times. 
Each specialized cell type requires a specific set of genes to be active while repressing 
transcriptional programs of alternative fates. One of the most common mechanisms of 
differentiation involves the controlled upregulation or downregulation of specific genes at the 
genomic level. DNA in cells is wrapped around proteins called histones to create a more compact 
form called chromatin that takes up less space in the nucleus. There are 5 such histones, called H1, 
H2A, H2B, H3, and H4. Two of each histone H2A, H2B, H3, and H4 come together to form an 
octamer around which DNA is wrapped. This unit is called a nucleosome. Multiple nucleosomes 




histone proteins can result in loosening or tightening of the DNA at that site. That DNA is then 
more or less accessible to transcription machinery, leading to increased or decreased expression of 
genes at that locus. Such modifications are not permanent. Rather, they can be added and removed 
by various proteins and protein complexes.  
 
Polycomb Regulation 
Figure 1: H2A Monoubiquitination Regulatory Axis  
Diagram showing components of the H2A Monoubiquitination Regulatory Axis which dynamically regulate 
placement of a ubiquitin mark on histone H2A. 
 
One important group of proteins involved in development and fate specification is 
Polycomb-group (PcG) proteins. PcG proteins are very conserved across organisms and are 
involved in the silencing of genes (Aranda et al. 2015, Schuettengruber et al. 2017). These proteins 
often function in very large complexes with multiple other proteins (Chittock et al. 2017). The 
polycomb-repressive deubiquitination complex (PR-DUB) is one such protein complex that 




Monoubiquitination of histone H2A (H2AUb1) at this site is a repressive chromatin mark with 
transcriptional silencing effects on nearby genes. This ubiquitin mark, which is dynamically 
removed by PR-DUB, is initially added by polycomb-repressive complex 1 (PRC1). PRC1 is a 
large complex consisting of a Ring1 protein, a Polycomb Group Ring Finger protein, and multiple 
other important proteins. Together, PRC1 and PR-DUB form the H2A monoubiquitination 
regulatory axis (Fig. 1) (Srivastava et al. 2017). My lab studies this regulatory axis, with particular 
focus on one protein component of the PR-DUB complex, called Additional Sex Combs - Like 3 
(ASXL3). 
 
Chromatin Regulatory Gene Asxl3 
A few years ago, my lab started studying Asxl3, which was known to be a chromatin 
regulatory gene predicted to function as a component of the PR-DUB complex (Katoh et al. 2004, 
Scheuermann et al. 2010). Bainbridge-Ropers Syndrome (BRS), a syndromic form of Autism 
Spectrum Disorder (ASD), is known to be caused by de novo dominant mutations in Asxl3 
(Bainbridge et al. 2013, Dinwiddie et al. 2013). This gene was thought to function in a complex 
that removes a monoubiquitination mark from histone H2A, and early work in my lab 
demonstrated that changes in H2A monoubiquitination levels were a key molecular mechanism 
causing the symptoms associated with BRS (Srivastava et al. 2016). Individuals with BRS tend to 
present with global developmental delay, hypotonia, intellectual disability, and autistic features 
including sleep, gastrointestinal, and verbal deficits (Balasubramanian et al. 2020). It has been 
found that symptoms of BRS are partially penetrant, and each patient may have different clinical 




According to the Center for Disease Control and Prevention, ASD is a complex 
neurodevelopmental disorder affecting around 1 in 54 children in the United States. Children with 
ASD most often present with intellectual disabilities and social impairment, along with a myriad 
of other comorbidities, including Attention Deficit Hyperactivity Disorder (ADHD), anxiety 
disorder, and epilepsy. Previously, there was debate surrounding the causes of ASD, and it was 
unclear whether genetics or environmental factors played a larger role (Hultman et al. 2004). 
However, through the use of twin studies and whole exome sequencing analyses, it has been 
determined that there is a prominent genetic basis for the disorder (Bailey et al. 1995, Geschwind 
et al. 2007). The genes that are commonly mutated in ASD patients encode proteins that fall into 
three categories – chromatin regulators, transcription and splicing factors, and synaptic proteins 
(De Rubeis et al. 2014, Iossifov et al. 2014). It has been hypothesized that these cell and molecular 
activities are disrupted during early development leading to common ASD pathology (Voineagu 
et al. 2011). How these functional gene classes contribute to a convergent pathogenic mechanism 
remains unknown. ASXl3 was identified as a high confidence ASD gene in studies that evaluated 
ASD cohorts in excess of 35,000 individuals (Satterstrom et al. 2020). However, virtually nothing 
was known about the function of ASXL3 during early development and in pathogenic 
mechanisms. Work in my lab focuses on characterizing the impacts of the important Polycomb 
group gene Asxl3 and the H2A monoubiquitination regulatory axis on development, specifically 
in the brain and heart. 
 
Corticogenesis 
Previous studies investigating post-mortem tissue in animal and human ASD models 




cortex (Kemper et al. 1998, Bailey et al. 1998). During normal development of the cortex, a process 
termed corticogenesis, cortical neurons are sequentially produced by a common pool of 
multipotent neural progenitor cells (NPCs). Corticogenesis occurs in an inside out fashion with 
NPCs beginning with the production of layer 6 deep layer neurons, before restricting their fate to 
produce the subsequent neuronal layers. The mature cerebral cortex contains six layers (L1-6) of 
cortical neurons and glia, with Layer 1 on the outer periphery of the brain and Layer 6 towards the 
core of the brain. Mature cortical neurons in each layer display distinct morphologies, axonal 
projections, and gene expression patterns required for cognitive function and complex behaviors. 
These cortical neuron subtypes are sequentially generated through progressive lineage restriction 
of the common NPC pool (Desai et al. 2000, McConnell et al. 1995, Shen et al. 2006). 
Developmental remodeling of histone modifications, accompanied by reorganization of cell type 
or lineage specific transcriptional programs, is a pivotal early step in the signaling cascade that 
leads to acquisition of new cellular identities (Corley et al. 2007). The spatial and temporal 
regulation of chromatin changes influencing the transcription circuitry that determines NPC fate 
are only beginning to be understood. Insults at many stages of this developmental process can alter 
the production of neuronal subtypes, leading to downstream consequences on neuronal 
connections required for normal brain function (Adam et al. 2020). 
 
Chromatin and Congenital Heart Defects  
Congenital heart defects (CHD) are the most common birth defect, affecting ~1% of all 
live births (Triedman et al. 2016). Next-generation sequencing has been instrumental in identifying 
pathogenic de novo dominant variants in genes that encode components of chromatin modifying 




cases, the chromatin genes identified are also known ASD risk genes, and individuals harboring 
these de novo mutations have a neurodevelopmental disorder (Jin et al. 2017). The role of ASXL3 
in mammalian heart development and causation of congenital heart defects is unknown. Human 
genetic studies and mouse models suggest an important role for Polycomb regulation during heart 
development (Delgado-Olguín et al. 2012; He et al. 2012a; Ai et al. 2017b; Chrispijn et al. 2019; 
Shirai et al. 2002; Mysliwiec et al. 2011, McGinley et al. 2014, Lee et al. 2012). Whole exome 
sequencing of individuals diagnosed with tetralogy of Fallot and ventricular septal defects 
identified compound heterozygous variants in ASXL3 (Fu et. al 2020). When the Asxl3 homologs 
Asxl1 and Asxl2 are knocked out, the null mice exhibit multiple congenital heart defects (McGinley 
et al. 2014). Together this data points to an important yet undescribed role for dynamic regulation 
of H2AUb1 by Asxl3 during heart development. 
 
Cardiogenesis 
Improper formation of the heart leads to congenital heart defects. The construction of the 
heart starts at the early stages of embryogenesis with two cardiac progenitor populations termed 
the first and second heart field. The first heart field gives rise to the left ventricle and a portion of 
the left atrium, while the second heart field gives rise to the entire right heart, a portion of the right 
atrium and the outflow tracts. Initially, the cardiac progenitors give rise to a primitive heart tube 
which undergoes looping, chamber specification, septation, and trabeculation before forming the 
four-chambered heart (Buckingham et al. 2005). This highly organized process depends on 
complex tissue dynamics, cell-cell signaling, and temporal regulation of lineage specific gene 
expression programs (Bruneau et al. 2013, Miquerol et al. 2012, Srivastava et al. 2006, Olson et 




cardiomyocytes, endocardial cells, epicardial cells, cardiac fibroblasts, and conductive cells (Cui 
et al. 2019, Delaughter et al. 2016). While this diversity is beginning to be uncovered, how this 
diversity is generated and how each cell type influences proliferation and differentiation programs 
remains to be determined.  
 
Thesis Goals 
My research work and that of others in my lab has focused on understanding the role of 
ASXL3 in development, particularly in the development of the brain and the heart. Based on earlier 
research findings, we hypothesized that ASXL3 regulates H2A monoubiquitination, the regulation 
of which is critical for regulation of transcription networks which determine fate for developing 
tissues. We hypothesized that disruptions of these key transcription networks would result in organ 
level defects underlying loss of Asxl3. To study these ideas, we engineered an Asxl3 knockout 
mouse model with CRISPR-Cas9 DNA editing technology. These mice have shown multiple 
defects from birth, and the goals of this thesis were to characterize two of the most prominent 
phenotypes – developmental delays in the formation of the neocortex of the brain and hypoplastic 






Materials and Methods 
 
Animals 
All experiments were performed in accordance with animal protocols approved by the Unit 
for Laboratory Animal Medicine (ULAM) at the University of Michigan. The Asxl3 null mice line 
was generated by cloning sgRNAs that target a region in exon 12 into a pX330 vector. The vectors 
were microinjected into fertilized eggs before being transferred into pseudopregnant C57BL/6 X 
DBA/2 F1 females. Topo cloning and Sanger sequencing were used to detect a unique frameshift 
Asxl3 allele. The loss of Asxl3 expression was validated by qRT-PCR and western blot. Asxl3+/- 
mice were maintained on a C57BL/6 background. Heterozygous breeding was used for 
experiments with E0.5 established as the day of vaginal plug.  
 
Western Blot Analysis  
Total cerebral cortices from E13 Asxl3+/+ and Asxl3fs/fs mice were homogenized in RIPA 
buffer supplemented with protease inhibitor cocktail and phosphatase inhibitor cocktail 3 obtained 
from Sigma-Aldrich (P8340 and P0044; St Louis, MO, USA). Protein levels were normalized after 
BCA analysis. Cell lysates were separated using electrophoresis on 4-20% SDS-polyacrylamide 
gels and transferred to PVDF membrane (Millipore, Billerica, MA, USA). For western blot, after 
the transfer, the PVDF membrane was blocked with 4% milk and incubated with the following 
antibodies overnight. Primary antibodies used were: anti-ASXL3 (1:50, Bielas Lab), anti-
ubiquityl-Histone H2A (1:2000, Cell Signaling Technology), anti-H3 (1:5000, Abcam). HRP-
conjugated secondary antibodies sc-2005, sc-2030 from Santa Cruz Biotechnology (Dallas, TX, 




chemiluminescence detection were performed according to manufacturer’s instruction 
[ThermoFisher Scientific (Waltham, MA, USA) cat no. 34095]. 
 
Immunohistochemistry and Counting  
Brains were dissected and removed from mice at E13, E14, E15, or P0 and then kept in 4% 
PFA at 4℃ overnight. Brains were cryopreserved by submersion in 20% then 30% sucrose 
solutions and embedded in OCT cryosectioning media (Tissue-Tek, Torrance, CA). 13 µm 
cryosections were obtained. After thawing, sections were incubated with PBS for 15 min to wash 
away OCT. For antibodies that required antigen retrieval, cryosections were heated in 10 mM 
sodium citrate for 20 minutes at 95℃ followed by incubation at room temperature for 20 minutes 
and 3 PBS washes. Sections were then incubated with a normal donkey serum blocking buffer [5% 
NDS (Jackson ImmunoResearch), 0.1% Triton X-100, 5% BSA] for 1 hour. Subsequently, they 
were incubated with primary antibodies diluted in blocking buffer at 4℃ overnight, washed with 
PBS, and stained with secondary antibodies at room temperature for 1 hour. Slides were washed 
with PBS, incubated with DAPI for 5 minutes, and coverslipped with MOWIOL. Images were 
acquired with a Nikon A1 confocal microscope and processed with LAS X software. Cells were 
counted using ImageJ. Briefly, images were segmented using Trainable Weka Segmentation 
(Arganda-Carreras et al 2017). After thresholding the segmented images, overlapping objects were 
separated with watershed and then counted with analyzed particles. Primary antibodies and 
dilutions used: anti-TBR1 (1:200, Abcam), anti-BCL11B (1:500, Abcam), anti-SATB2 (1:100, 
Abcam), anti-L1CAM (1:300, Millipore), anti-SOX2 (1:500, Neuromics), anti-TBR2 (1:500, 





EdU Birthdate Analysis  
Females from time pregnant matings were injected with EdU (20 mg/kg) at embryonic day 
13 or 14 (E13 or E14). 24 hours later or at P0, brains were dissected and removed from EdU 
injected pups and then kept in 4% PFA at 4℃ overnight. EdU labeling was detected in cryosections 
by using the Click-IT EdU imaging kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
instructions. After sections were incubated with Click-IT reaction cocktail, they were washed with 
normal donkey serum blocking buffer. Then, additional antibody staining was performed. 
 
Cresyl Violet Staining  
P0 and P2 Brains were dissected and kept in 4% PFA overnight. Fixed brains were 
dehydrated in a series of ethanol washes and embedded with a paraffin tissue processor. 6 µm 
microtome sections were dewaxed and rehydrated in series of xylene and ethanol washes, stained 
with 0.5% Cresyl Violet, dehydrated with ethanol, and cleared with xylene. 
 
Collection of Cells for Single-Cell RNA Sequencing 
The cerebral cortices from E13, E14, and P0 brains were dissected in Earl’s balanced salt 
solution (EBSS). Isolated cortices were incubated with pappain (Worthington Biochemical 
Corporation), 5.5 mM L-cysteine-HCL, 1.1 mM EDTA, and 100 mg/ml DNase I in O2:CO2 
equilibrated EBSS for 8 minutes at 37℃. Samples were titrated with flame tipped glass pipettes 
and centrifuged at 800 RCF for 5 minutes. Cells were resuspended with an ovomucoid protease 
inhibitor (Worthington Biochemical Corporation) and 50 mg/ml DNase I in O2:CO2 equilibrated 
EBSS then passed through a 70 micron cell strainer. Cells were centrifuged in a gradient of 




NB/B27 media. Cells were counted and checked for viability with the Luna automatic cell counter 
(Logos Biosystems) before loading onto a Seq-Well platform. 
 
Seq-Well Single-Cell RNA Sequencing 
Seqwell was performed as described (Aicher et al. 2019, Gierahan et al. 2017). Briefly, 
functionalized Seq-Well arrays, containing 90,000 picowells, were loaded with barcoded beads 
(ChemeGenes, Wilmington, MA). 20,000 cells were loaded onto the arrays and incubated for 15 
minutes. To remove residual BSA and excess cells, arrays were washed with PBS. Functionalized 
membranes were applied to the top of arrays, sealed in an agilent clamp, and incubated at 37℃ for 
45 minutes. Sealed arrays were incubated in a lysis buffer (5 M guanidine thiocynate, 1 mM 
EDTA, 0.5% sarkosyl, 1% BME) for 20 minutes followed by a 45-minute incubation with 
hybridization buffer (2 M NaCl, 1X PBS, 8% PEG8000). Beads were removed from arrays by 
centrifuging at 2000xg for 5 minutes in wash buffer (2 M NaCl, 3 mM MgCl2, 20 mM Tris-HCl 
pH 8.0, 8% PEG8000). To perform reverse transcription, beads were incubated with the Maxima 
Reverse Transcriptase (Thermo Scientific) for 30 minutes at room temperature followed by 
overnight incubation at 52℃. Reactions were treated with Exonuclease 1 (New England Biolabs) 
for 45 minutes at 37℃. Whole transcriptome amplification was performed using the 2X KAPA 
Hifi Hotstart Readymix (KAPA Biosystems). Beads were split to 1,500-2,000 per reaction and run 
under the following conditions: 4 Cycles (98℃, 20s; 65℃, 45s; 72℃, 3m), 12 Cycles (98℃, 20s; 
67℃, 20s; 72℃, 3m), and final extension (72℃, 3m, 4℃, hold). Products were purified with 
Ampure SPRI beads at a 0.6X volumetric ratio then a 1.0X volumetric ratio. Libraries were 
prepared using the Nextera XT kit (Illumina) and libraries were sequenced on an Illumina NextSeq 





Preprocessing of Seq-Well Data 
Sequencing reads were processed into a digital gene expression matrix using Drop-seq 
software (Macosko et al. 2015). FASTQ files were converted into bam files before being tagged 
with cell and molecular barcodes and trimmed. After converting back to FASTQs, reads were 
aligned to mm10 with STAR. BAM files were then sorted, merged, and tagged with gene exons. 
Bead synthesis errors were corrected and digital gene expression matrices were generated. For 
downstream analysis, cells with fewer than 300 detectable genes, greater than 5,000 genes, or 
greater than 10% mitochondrial genes were removed. We then visualized the raw count of 
hemoglobin genes (Hbb-bh1, Hba-a2, Alas2, Hbb-y, Hbb-bs, Fam46c, Hbb-bt, Hba-a1, Hmbs, 
Fech, Slc25a37) using Violin plot to set a threshold for filtering blood cells. We normalized the 
data in each sample for each cell by dividing the total counts for that cell and multiplied by the 
10,000. This was then natural-log transformed using log1p. After this normalization step, we 
selected genes showing a dispersion (variance/mean expression) larger than two standard 
deviations away from the expected dispersion as variable genes using the Seurat (v3.1.2) function 
“FindVariableGenes” for each sample. We believed that these genes have the biggest variation 
across cells, so focusing on these genes would give us the most information as described in the 
Seurat guideline. In this way, 2000 significant genes were identified using variance stabilizing 
transformation for each sample in different stages. We then used these most informative genes for 







Histology and Morphometric Measurements of Cardiac Tissue  
Newborn mice were sacrificed and whole bodies were fixed for 24 h in 4% 
paraformaldehyde, dehydrated, and embedded in paraffin. Paraffin blocks were serially sectioned 
at 5 µm thickness and stained with Hematoxylin/eosin and Masson’s trichrome. All measurements 
of left ventricle free wall, right ventricle free wall, interventricular septum, left wall thickness, and 







Mouse Model Shows Disruptions in H2A Monoubiquitination Levels 
In order to study the role of Asxl3 in development, we engineered an Asxl3 knockout mouse 
model using CRISPR-Cas9 DNA editing technology. Based on whole exome sequencing results, 
we targeted exon 12 of Asxl3 to create clinically relevant variants that function as null alleles. 
Western blots for ASXL3 demonstrated the absence of protein, confirming the Asxl3 frameshift 
(fs) variants function as loss-of-function alleles in null animals (Fig. 1A). Although we have 
studied the wild type, heterozygous, and null phenotypes, my work here specifically compares 
wild type and null mice. We observe skewed Mendelian ratios, perinatal lethality, and a 3-fold 
elevation of H2AUb1 levels in null mice (Fig. 1B, C and data not shown). The increase in H2AUb1 
levels is consistent with results from patient-derived fibroblasts and ASXL3 edited human ES cells 
(Srivasta et al. 2015). In accordance with Asxl3 being a Polycomb group gene, we observe 
abnormalities in multiple organ systems. Phenotypes include a homeotic transformation, cardiac 
defects, and nervous systems defects. Asxl3 null mice display drooping forelimbs and abnormal 
body curvature indicative of a neuromuscular defect (Fig. 1D) (Turgeon et al. 2009). In null mice, 
cerebellar foliation appears delayed with shallower fissures and smaller lobules (Fig. 1G). 
Perinatal lethality and the largely postnatal development of the cerebellum prevented further 
investigation of this phenotype with our current mouse model. 
A major area of focus for my thesis was the cerebral cortex and its development. By 
measuring the area of whole mount cerebral cortices, we find that null mice have a significantly 
decreased cortical area on average compared to the wild type mice (Fig. 1E, p = 0.009). We detect 




however cortical layering looks defective with a lack of clearly distinct boundaries between layers 
(Fig. 1F). Together these findings are consistent with the idea that Asxl3 is an important Polycomb 
group gene required for proper development of the brain, among other organs. 
Figure 2: Asxl3 knockout mouse model and defects in early development  
A) Western blot to confirm efficacy of Asxl3 knockout. B) Western blot for H2AUb1 and H3 on acid extracted histones 
from E13.5 cortices. C) Quantification of H2AUb1 levels relative to H3 in wild type and null mice. Values are mean 
± SEM. D) Appearance of curved back and drooping forelimbs in P0 Asxl3fs/fs mice. E) Cortical surface area 
measurements show decreased cortical area in Asxl3fs/fs mice (p = 0.009). Values are mean ± SEM. F) Cresyl Violet 
staining of P0 cerebral cortex G) A reduction in cerebellar foliation is observed in sagittal sections of P2 null mice.  
 
Reduction in Layer 5 Neurons and Defects in Cortical Spinal Tract 
During the development of the cerebral cortex, multipotent NPCs differentiate into mature 
neurons that are organized into 6 layers (L1-6). Neurons within each layer have unique expression 




complex behaviors. Defects in this process can have major downstream consequences on brain 
function. To investigate potential cortical layering changes in null animals, we perform 
immunohistochemistry (IHC) for layer specific markers. Using P0 cortical tissue, we probe for 
TBR1, BCL11B, and SATB2, which mark Layer 6, Layer 5, and Layer 2-4 cells respectively (Fig. 
3C). Following quantification of the layer markers, we find no significant difference between the 
number of TBR1+ layer 6 neurons and SATB2+ layer 2-4 neurons across genotypes (Fig. 3D). We 
do observe a ~25% reduction in BCL11B+ cells in null cortices (Fig 3D). Interestingly, conditional 
deletion of Ring1B from the cortex during neurogenesis leads to a ~30% increase in BCL11B+ 
cells (Morimoto-Suzki et al. 2014). The opposing L5 lamination defects mirror the opposing 
catalytic activity of PRC1 and PR-DUB, implicating a role for dynamic regulation of H2AUb1 in 
specifying mature cortical neurons. 
Figure 3: Reduction in layer 5 BCL11B+ neurons and corticospinal tract defects 
A) Diagram showing the axons of BCL11B+ L5 neurons projecting subcerebrally via the corticospinal tract B) In 
Asxl3fs/fs, the density of L1CAM stained axons in the corticospinal tract is reduced. C) TBR1 (layer 6), BCL11B 
(layer 5), and SATB2 (layer 2-4) immunolabeled coronal neocortex sections at P0. D) Quantification of TBR1, 
BCL11B, and SATB2 positive cells in a radial column. Values are mean ± SEM. 
 
 BCL11B+ L5 neurons are upper motor neurons which extend their axons to subcerebral 




information and our earlier findings, we investigate the corticospinal tract (CST) by staining 
sagittal sections with L1CAM, a transmembrane protein expressed by neuronal axons. In 
accordance with reduced BCL11B+ L5 neurons, the density of axons in Asxl3 null mice is 
sparse near the pons where the CST typically bundles (Fig. 3B). These results suggest a defect in 
neurogenesis which leads to disrupted generation of mature neurons and their corresponding 
axons. 
 
Reduction in Layer 5 Neurons is Caused by a Delay in Differentiation 
 Since neurons are born from a common pool of progenitors, we hypothesize that a delay in 
differentiation causes the reduction in L5 neurons. To study this, we use a series of EdU birthdating 
experiments. Our EdU birthdating protocol involves injecting time pregnant mice with EdU at 
embryonic stages and collecting pups at P0. EdU is a thymidine analog that incorporates into cells 
undergoing DNA synthesis. Within the cortex, progenitor cells in the ventricular zone and 
subventricular zone are the only cells undergoing DNA replication. After the litter is taken and the 
brains are dissected and stained, the neurons born on the day of the EdU injection can be visualized 
(Fig. 4A). We use this approach to look at neurons born at two embryonic time points: embryonic 
day 13 (E13) and embryonic day 14 (E14). These time points are chosen to capture the production 
of L5 neurons that occurs between E12.5 to E14.5. 
Pairing the detection of EdU labeling with immunostaining for BCL11B+ allows us to 
determine the L5 differentiation dynamics. No appreciable difference between the number of 
BCL11B+/EdU+ co-labeled cells exists between Asxl3+/+ and Asxl3fs/fs E13 EdU injected mice 




BCL11B+/EdU+ co-labeled cells (Fig 4B, C, D). This reduction suggests that a delay in 
differentiation during neurogenesis underlies the deficit of layer 5 neurons. 
Figure 4: Layer 5 neuron reduction in null mice is the result of a delay in differentiation  
A) Schematic depicting EdU birthdating experimental design. Time pregnant mice received EdU treatment at E13 or 
E14 and visualization of EdU+ cells occurred at P0. B) Representative images of BCL11B+/EdU+ co-labeled cells in 
P0 cortices of E13 (left) and E14 (right) injected mice. C) Insets of B. White circles mark BCL11B+/EdU+ co-labeled 
cells. D) No difference exists in the number of co-labeled cells at E13, but there is a reduction at E14 in Asxl3fs/fs 
cortices (p = 0.018). Values are mean ± SEM. 
 
Delay in Differentiation Caused by Expansion in NPCs 
To delineate the molecular mechanism responsible for impaired differentiation dynamics, 
we perform single-cell RNA sequencing (scRNA-seq). Using the Seq-Well platform, we conduct 
scRNA-seq with E13 and E14 wild type and null cortical tissue. Through dimensionality reduction 
and unsupervised clustering with uniform manifold approximation and projection (UMAP), we 
identify 12 cell clusters at E13 and 10 cell clusters at E14 (data not shown). Clusters are annotated 
according to expression of known cell type markers. The identified cell populations correlate to 




progenitors, intermediate progenitors, migrating neurons, and excitatory neurons. Comparing the 
cellular composition of wild type and null samples shows an increase in the proportion of 
progenitor cells and a decrease in the proportion of intermediate progenitors, immature migrating 
neurons, and mature deep layer excitatory neurons in null samples at E13 (Fig. 5B). By E14, 
however, we find that the proportion of progenitor cells is roughly equivalent in both cortices. 
Instead, the null cortices are showing significantly increased levels of differentiating progenitors 
when compared to the wild type cortices (Fig. 5B). The expanded progenitor population in null 
cortices at E13 turns into an expanded differentiating progenitor population in null cortices at E14. 
By conducting these experiments across multiple developmental time points, we can see that 
neuronal differentiation is delayed and progenitor multipotency is maintained in Asxl3 null mice. 
The dynamics of cell fate restriction appear to be altered in Asxl3 null mice. 
Next, we confirm these composition changes detected by scRNA-seq with IHC in cortical 
tissue. We perform immunofluorescent staining for SOX2 and TBR2 with E13 cortical tissue. 
SOX2 marks neural progenitor cells in the ventricular zone and TBR2 marks intermediate 
progenitors in the sub-ventricular zone (Fig. 5A). Quantification of SOX2+ cells in the medial and 
lateral neocortices shows increases in the lateral neocortex of null cortices but not in the medial 
neocortex (Fig. 5D). We also find that the null cortices have decreased TBR2+ cells in the medial 
neocortex but not in the lateral neocortex. The change in SOX2+ progenitors seems modest 
compared to the scRNA-seq results. Therefore, we measure the apical length or the perimeter of 
the ventricles, as shown by the dotted line in (Fig. 5A). Our analysis reveals that null cortices have 
longer apical lengths relative to their wild type counterparts at E14 (Fig. 5C). Increased apical 
length indicates lateral expansion of neural progenitor cells and strongly supports the idea that at 




cortices show no significant difference (data not shown), demonstrating that null cortices have 
overcome differentiation deficits. Importantly, the trends we observe with our IHC and apical 
length data correspond with the composition changes detected by scRNA-seq. Evidence from our 
data shows that null cortices experience an expansion in NPCs with a corresponding delay in 
neuronal differentiation. These developmental defects in fate specification underlie changes in 
cortical composition at P0. 
Figure 5: Asxl3 deficiency inhibits neurogenesis 
A) Expression of SOX2 (green) and TBR2 (red) in the E14 neocortex. B) Single-cell RNA sequencing performed with 
E13 and E14 cortical tissue. Bar graphs depict the cellular composition of major cell types in Asxl3+/+ and Asxl3fs/fs 
cortices at these time points. C) Apical length (measurement shown in A with dotted line) is increased in E14 Asxl3fs/fs 
mice. Values are mean ± SEM. D) The number of SOX2+ and TBR2+ cells in the E14 medial and lateral neocortex 






Various Congenital Heart Defects Detected in Null Mice 
In addition to the neuronal defects, the Asxl3fs/fs and Asxl3+/fs mice present with partial 
penetrance of several congenital heart defects (Fig. 6B). Early imaging and staining, made it clear 
that the heterozygous and null mice hearts have some degree of cardiac malformation. With whole 
mount imaging, we observe separated ventricles and a bifid cardiac apex in several P0 hearts (Fig. 
6A). These phenotypes are not observed in any of the wild type hearts but are present in a number 
of the heterozygous and null mice (Fig. 6B). 4.5% of heterozygous mice show separated ventricles, 
while 16.6% of null mice show separated ventricles and 16.6% have a bifid cardiac apex. Next, 
we examine heart morphology with hematoxylin and eosin (H&E) staining of serial sections. From 
our analysis, we find clear septal defects and hypoplastic ventricular cavities in heterozygous and 
null mice (Fig. 6C). Hypoplastic ventricles is the most penetrant phenotype, with 12.5% of 
heterozygous mice and 28% of null mice displaying this phenotype (Fig. 6B). In the hearts with 
hypoplastic ventricular cavities, the ventricles appear incomplete and hypoplastic throughout the 
entirety of serial sections (data not shown). While this phenotype is observed in both right and left 
ventricles, right ventricles are more frequently affected. We believe that these congenital heart 







Figure 6: Asxl3-associated congenital heart defects  
A) Whole-mount examination of P0 hearts shows separated ventricles and bifid cardiac apex in heterozygous and null 
mice. B) Penetrance of cardiac abnormalities in Asxl3+/+, Asxl3+/fs, and Asxl3fs/fs P0 mice. C) Representative 
hematoxylin and eosin staining of transverse P0 sections revealing septal defects and ventricular hypoplasia.  
 
 We began to assess the consequences and biological mechanism of the cardiac 
abnormalities we detect in our Asxl3 model. Null hearts weigh significantly more than wild type 
hearts, but no difference is observed in heterozygous mice (Fig. 7A, p = 0.0083). Similarly, the 
heart weight to body weight ratios are increased in null mice relative to the wild type mice, but 
there is no change in heterozygous mice (Fig. 7B, p = 0.0070). Following this analysis, we take a 




knockout of Asxl3. Specifically, we look at the right wall thickness (RWT), right ventricular lumen 
width (RVLW), interventricular septum thickness (IVS), left ventricular lumen width (LVLW), 
and left wall thickness (LWT) (Fig. 7C). The thickness of the two walls and the IVS are statistically 
equivalent, but the two lumen widths distances are statistically decreased in the null hearts (Fig. 
7D, p < 0.0001 for RVFW and p < 0.001 for LVFW). The reductions in the open lumen space of 
the ventricles in the null hearts correlate with cardiac defects we saw in the H&E stained cardiac 
tissue. The phenotype is consistent with the hypoplastic ventricular cavity noted earlier. 
Morphologically, the outer walls and the septum were not different in the null hearts compared to 
the wild type hearts. 
Figure 7: Heart morphology of Asxl3 mouse model 
A) Asxl3fs/fs heart weights and B) heart-body weight ratio are significantly increased relative to Asxl3+/+ with no 
significant change in Asxl3+/fs mice. C) Schematic diagram of morphometric measurements. D) Graphs depict relative 
morphometric measurements of P0 hearts. The RVLW and LVLW are significantly reduced in Asxl3fs/fs relative to 
control. RWT, right wall thickness; RVLW, right ventricular lumen width; IVS, interventricular septum; LVLW, left 





Reduced Ventricular Space is Due to Increased Proliferation in Null Hearts 
  The ventricular walls and septum appear thicker in hearts with hypoplastic ventricular 
cavities (Fig. 6C). We predict that several mechanisms can be responsible for the changes in 
chamber development including increased cardiomyocyte size (hypertrophy) or proliferation 
defects (hyperplasia). Based on the finding that ventricular space is reduced as a result of Asxl3 
knockdown, we hypothesize that cells in the ventricles of null hearts might undergo increased 
proliferation relative to such cells in wild type hearts. To test this hypothesis, we conduct additional 
EdU birthdating experiments (Fig. 8A). Time pregnant mice are injected with EdU at E13. A day 
later, at E14, we analyze the left ventricle, septum, and right ventricle from wild type, 
heterozygous, and null mice, at which point the heart is actively developing. No significant 
differences are noted in EdU positive cells in the septum (Fig. 8B). In the left ventricle, the 
heterozygous and null hearts both show increased levels of EdU positive cells relative to the wild 
type hearts (Fig. 8B). In the right ventricle, the difference between the heterozygous and wild type 
hearts is not as significant, but there is a significant increase in the number of EdU positive cells 
in the null heart relative to the wild type heart (Fig. 8B). Overall, null hearts tend to show increased 
levels of EdU positive labeled cells in the left and right ventricles at E14. This is consistent with 





Figure 8: Increased proliferation during heart development 
A) EdU labeled E14 left and right ventricles from Asxl3+/+, Asxl3+/fs and Asxl3fs/fs hearts. E13 time pregnant mice 
were treated with EdU and embryos were collected a day later. B) The percentage of EdU+ cells is increased in E14 
Asxl3+/fs and Asxl3fs/fs left ventricles and Asxl3fs/fs right ventricles. Values are mean ± SEM. 
 
Reduction in Vimentin Positive Cells in Null Ventricular Walls 
During development, cardiomyocyte proliferation is regulated by interactions with other 
cells, signaling pathways, transcriptional programs, the extracellular matrix (ECM), and cellular 
metabolism. Bulk RNA sequencing of E18 hearts reveals dysregulation of extracellular matrix 
components and corresponding receptors along with cell signaling players in heterozygous and 
null mice (data not shown). We observe similar results from single-cell RNA sequencing 
experiments with ASXL3 edited human embryonic stem cells differentiated toward the cardiac 
lineage (data not shown). Cardiac fibroblasts deposit the majority of extracellular matrix 
components in the developing heart. The excreted ECM from embryonic cardiac fibroblasts 
promotes cardiomyocyte proliferation through ECM receptor signaling pathways (Ieda et al. 
2009). Given the ECM changes we detect with RNA-seq and increased proliferation at E14, we 
choose to investigate potential cardiac fibroblasts deficits. Coronal sections of P0 hearts are 
immunostained with Vimentin, an intermediate filament protein that marks cardiac fibroblasts 
(Fig. 9). Vimentin+ cells are quantified in the left and right ventricles as well as the septum (Fig. 




Vimentin+ fibroblast in the septum across genotypes. In both ventricles, heterozygous and null 
samples show significant reductions in the number of Vimentin positive cells relative to wild type 
samples (Fig. 9A, B, C). These findings support the idea that Asxl3 functions in cardiac 
development and suggests that knocking down Asxl3 may have downstream consequences such as 
the disrupted collagen and decreased number of cardiac fibroblasts observed in the heterozygous 
and null hearts. 
Figure 9: Asxl3+/fs and Asxl3fs/fs hearts lack VIM+ cells. 
A) Immunofluorescent staining of P0 left ventricles with Vimentin and nuclei stained with DAPI. B) Percentage of 
Vimentin+ cells located in the right ventricle, septum, and left ventricle of Asxl3+/+, Asxl3+/fs and Asxl3fs/fs P0 
hearts. Values are mean ± SEM. C) Immunofluorescent staining of P0 right ventricles with Vimentin and nuclei stained 
with DAPI. D) Schematic of P0 transverse heart sections depicting representative regions of images from A&C. 
 
Our collective data of Asxl3 in corticogenesis and cardiogenesis, illustrate its fundamental 
role in regulating developmental processes during organogenesis. In both organ systems, Asxl3 
appears necessary to shape proliferation and differentiation dynamics. Without the function of 








During early development, multipotent cells must restrict their fate in a highly regulated 
manner to ensure the production of the right mature cell types in the right locations. Chromatin 
plasticity and the dynamic addition and removal of chromatin marks is an important aspect of this 
fate specification process (Yadav et al. 2018). Certain chromatin marks loosen the structure of the 
chromatin and nucleosomes, allowing transcription machinery to access the DNA wrapped around 
the histones. This increases gene transcription in that region. Other chromatin marks result in 
tightening of the DNA around the histones, blocking transcription machinery from accessing the 
DNA at that locus. In this way, transcription is repressed. The selective activation and repression 
of certain genes via chromatin regulation allows for each cell to closely control the differentiation 
process. 
Asxl3 is one of many genes known to be involved with chromatin regulation. ASXL3 helps 
the PR-DUB complex remove a ubiquitin mark from histone H2A. Previous studies have 
demonstrated that de novo truncating mutations in Asxl3 are the genetic cause of Bainbridge 
Ropers Syndrome (BRS), a developmental disorder which presents with symptoms and features 
consistent with other forms of autism spectrum disorder (ASD) (Bainbridge et al. 2013, Dinwiddie 
et al. 2013, Srivastava et al. 2016). Early work in my lab has shown that changes in H2A 
monoubiquitination levels, which are normally regulated by complexes like PRC1 and PR-DUB, 
were the key molecular pathology of BRS (Srivastava et. al 2016). Compared with other histone 
marks, there has not been a great deal of research on this particular chromatin mark. Further, much 
of the current H2AUb1 research uses embryonic stem cells, preventing a molecular understanding 




Existing research has not reached a consensus regarding the role of H2AUb1 in regulating gene 
transcription (Illingworth et al. 2015, Kundu et al. 2018, Blackledge et al. 2020, Tamburri et al. 
2020). Some researchers claim that the enzymatic activity of RING1B, a protein which functions 
in the PRC1 complex to add the ubiquitin mark to H2A, is not necessary for proper embryonic 
development (Illingworth et al. 2015). However, the Ring1b enzymatic null mice exhibited 
increased embryonic lethality and neurological defects, suggesting that Ring1b and proper 
regulation of H2A monoubiquitination is, in fact, necessary for development. Through the use of 
an Asxl3 knockout mouse model, my lab members and I have worked to better characterize the 
role of ASXL3 and H2AUb1 in early development. We have found that proper regulation of the 
H2AUb1 is necessary for early embryonic development. Our initial findings showed that Asxl3 
knockout was responsible for elevated levels of H2AUb1 and that this increase in H2AUb1 was 
also correlated with changes in progenitor behavior and fate specification during the development 
of multiple organ systems. The work described in this thesis has specifically focused on defects in 
neuronal development and cardiac development. 
 Human genetics has revealed many key players in ASD, namely chromatin, transcription 
and synaptic proteins (De Rubeis et al. 2014, Iossifov et al. 2014, Satterstrom et al. 2020). These 
proteins are crucial to proper and timely brain development, and loss of function in such proteins 
is thought to result in neurodevelopmental disorders. ASD may present in vastly different ways, 
but it is thought that there is a common set of pathways and molecular players whose disruption 
can be linked to many of these disorders (Parenti et al. 2020). These common pathways are not yet 
known, and it is unclear how variants in so many genes in different functional groups can lead to 
similar phenotypes (Sullivan et al. 2019). The genetic heterogeneity has made ASD difficult to 




phenotypes. We chose to study Asxl3 because it is a high confidence syndromic ASD risk gene 
with high effect size (Satterstrom et al. 2020). Given its role as a chromatin regulator, we predicted 
that Asxl3 might act as a hub gene to influence other known ASD risk genes. We hoped studying 
Asxl3 would provide insights into how genetics contribute to ASD pathology and the shared 
pathogenic mechanism that links the functional gene groups. Studying this important gene and 
understanding its role in causing BRS can provide a solid foundation for further research into other 
high confidence genes, as well. The work described in this thesis takes a step in that direction.  
Previous studies implicate disruptions to the development of deep layer excitatory neurons 
as the pathogenesis of ASD (Willsey et al. 2013). In accordance with that finding, we determined 
that loss of ASXL3 results in a reduction in the L5 upper motor neuron population. The reduction 
in this population was also apparent by the reduced density of the corticospinal tract (CST), which 
consists of the axons from L5 neurons. CST axons relay important motor signals from the cerebral 
cortex to targets in the spinal cord. The decrease in CST axons may be responsible for the curved 
back and drooping forelimb posture of Asxl3 null mice, a hallmark of neuromuscular defects. 
Further, we have shown that the reason behind this diminished L5 population is an increased 
maintenance of neural progenitor cells and a delay in neuronal differentiation. Intriguingly, the 
dysregulated genes we identified in our scRNA-seq studies were enriched for other known ASD 
risk genes, with chromatin and transcriptional genes more enriched at early stages and synaptic 
genes at later developmental stages (data not shown). Together this data suggests that Asxl3 
regulates other ASD risk genes to control NPC behavior during fate specification. Changes in this 
specification process ultimately have consequences on cortical connections that are responsible 




This work establishes the importance of H2AUb1 in the fate specification of 
NPCs. Experiments with Ring1b knockdown showed an opposing phenotype, with L5 neurons 
being increased (Morimoto-Suzki et al. 2014). The increase in L5 neurons in Ring1b null mice and 
the decrease in L5 neurons in the Asxl3 null mice were of roughly the same magnitude. Although 
some studies have suggested that regulation of this chromatin mark is not necessary for 
development (Illingworth et al. 2015), the opposing lamination defects in Ring1b and Asxl3 null 
mouse models support a role for H2AUb1 in neural differentiation and development. Currently, 
we are profiling H2AUb1 across the genomes of E13 NPCs using CUT&RUN analysis, a low 
input alternative to ChIP-seq. We hope to uncover the epigenomic mechanism of ASXL3-
dependent H2AUb1 chromatin remodeling within NPCs necessary for fate determination. 
 The fate specification process, in which neural progenitor cells (NPCs) sequentially 
restrict their fate to produce multiple layers of mature neurons, is critical to creating the correct 
structure and organization of the cerebral cortex (Adam et al. 2020). There is general consensus 
that the different mature neuron layers arise from a common pool of progenitors. These progenitors 
go through a highly regulated process in which, at each step, certain fates are restricted but other 
fates are allowed. The mechanism of selective fate restriction and the control of timing during this 
process is not fully understood, but our work helps make some headway in this field. Our work 
provides another data point that suggests that chromatin regulation plays an important role in this 
process. We showed that loss of ASXL3 alters the behavior of progenitors and leads to changes in 
the timing of differentiation during early development. Not only is this work applicable to BRS 
patients and the search for potential therapeutics for BRS patients, but it also provides further 
insights into the normal corticogenesis process and creates a foundation for studying other 




work has implications for many different areas of human genetics research. We are studying some 
fundamental mechanisms of brain biology. The findings outlined in this thesis contribute to our 
understanding of ASD biology and also demonstrate a general link between chromatin, 
transcription, and synaptic genes. When chromatin regulation is disrupted, transcription of certain 
genes is affected, and this has downstream consequences on many other processes. 
 Recent studies have shown that mutations in many genes that are known to be associated 
with neurodevelopmental disorders also contribute risk for congenital heart disease (Jin et al. 
2017). Specifically, in CHD patients, damaging de novo mutations were enriched in ASD-
associated chromatin modifiers, suggesting a link between cardiac and neuronal development (Jin 
et al. 2017). The findings from our mouse model support this. Loss of function in Asxl3 resulted 
in several congenital cardiac abnormalities, the most prominent being hypoplastic ventricles and 
thickened ventricular walls. This phenotype is reminiscent of the congenital heart disease 
hypoplastic left heart syndrome (HLHS). Individuals with HLHS have severely thickened left 
ventricular walls, resulting in reduction of the size of the left ventricular cavity (Grossfeld et al. 
2019). The particular phenotype we saw differs slightly in that we see these changes in both the 
left and right ventricles, as opposed to HLHS which only has these phenotypes in the left 
ventricular region. There are multiple proposed mechanisms that potentially cause these 
phenotypes. Some have suggested that reduced blood flow leads to thickening of the ventricular 
walls and the reduction in the cavities of the heart is attributed to reduced cardiomyocyte 
proliferation (deAlmeida et al. 2007). More recently it has been suggested that this abnormal 
structure may be the result of reduced endocardial function and cardiomyocyte hyperplasia 
(Grossfeld et al. 2019, Miao et al. 2020). We tested these potential mechanisms by investigating 




increased proliferation at E14, consistent with the second model. Cardiac fibroblasts derived from 
endocardium are known to influence cardiomyocyte proliferation dynamics through extracellular 
matrix signaling (Ieda et al. 2009). In our studies, we detected decreased numbers of fibroblasts 
and dysregulated ECM in Asxl3 null hearts. This lends further support to decreased endocardial 
function and increased proliferation of cardiomyocytes as the underlying mechanism responsible 
for the ventricular phenotypes. Importantly, our work is the first to demonstrate a role for 
chromatin regulation in this disease mechanism.  
Past research has also shown that when Asxl2 is knocked out, thickened ventricular walls 
and reduced luminal volume is also observed (McGinley et al. 2014). When components of the 
PRC1 or PRC2 complexes - which work antagonistically to the complexes involving ASXL2 and 
ASXL3 - are mutated, an opposite phenotype is observed. PRC1 and PRC2 knockout mice display 
left ventricular non-compaction resulting in thin ventricular walls (Chen et al. 2012, He et al. 2012, 
Mysliwiec et al. 2011). These studies support the idea that the H2A monoubiquitination regulatory 
axis is important for cardiac development. When there are insults to the regulation of this 
chromatin mark, cardiac abnormalities result. It appears that increased H2AUb1 across the genome 
yields thickened ventricular walls and hypoplastic cavities, whereas decreased H2AUb1 yields 
thinner ventricular walls and dilated cavities. 
 Chromatin regulators like ASXL3 have been shown to play important roles in embryonic 
development. Mutations in other members of the ASXL family, ASXL1 and ASXL2, are linked 
to developmental disorders and often result in significant abnormalities in organ structure 
(Hoischen et al. 2011, McGinley et. al 2014, Shashi et al. 2016). Developmental defects in similar 
organ systems can also be caused by mutations in PRC1 or PRC2 components (He et al. 2012, 




genetic findings provides evidence for the importance of Polycomb regulation in normal 
development and pathogenesis. Further research into proteins and complexes that modify this 
chromatin mark can provide significant insight into the processes of organ development and can 
help elucidate the pathology associated with the various disorders. This kind of work is important 
not only for expanding our understanding of early development, but also for providing potential 
targets for therapeutics for the patients with these disorders.  
Asxl3 research is relatively new, and there are many further studies that can be conducted. 
One potential next step would be to determine specifically where ASXL3 binds across the genome. 
ASXL3 has local effects on the chromatin, not genome-wide effects. Thus, determining where 
exactly ASXL3 binds can provide insight into the exact DNA regions that are impacted. Those 
DNA regions and the genes at those loci can be studied further to understand the role of ASXL3 
within larger signaling networks. Another potential step would be to do these experiments in 
human tissues. The experiments described here were performed using mouse models, so the results 
may not be completely representative of the function of human ASXL3. Further research using 
organoid models may help bridge some of these gaps. This field of research is still in its early 
stages. Through further research, we can expand our knowledge of how proteins like ASXL3 
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